相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors
Kwon-Ho Song et al.
NATURE COMMUNICATIONS (2020)
Relationships Between Immune Landscapes, Genetic Subtypes and Responses to Immunotherapy in Colorectal Cancer
Emilie Picard et al.
FRONTIERS IN IMMUNOLOGY (2020)
The HSP90 inhibitor Onalespib exerts synergistic anti-cancer effects when combined with radiotherapy: an in vitro and in vivo approach
Diana Spiegelberg et al.
SCIENTIFIC REPORTS (2020)
Neoadjuvant radiation for clinical T4 colon cancer: A potential improvement to overall survival
Alexander T. Hawkins et al.
SURGERY (2019)
Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer
Ganji Purnachandra Nagaraju et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Combination therapies with HSP90 inhibitors against colorectal cancer
Kushtrim Kryeziu et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2019)
Rebalancing Protein Homeostasis Enhances Tumor Antigen Presentation
Alex M. Jaeger et al.
CLINICAL CANCER RESEARCH (2019)
Migration through physical constraints is enabled by MAPK-induced cell softening via actin cytoskeleton re-organization
Dominika A. Rudzka et al.
JOURNAL OF CELL SCIENCE (2019)
Is There a Place for Immunotherapy for Metastatic Microsatellite Stable Colorectal Cancer?
Francois Ghiringhelli et al.
FRONTIERS IN IMMUNOLOGY (2019)
Radiosensitization of HSF-1 Knockdown Lung Cancer Cells by Low Concentrations of Hsp90 Inhibitor NVP-AUY922
Annett Kuehnel et al.
CELLS (2019)
KRAS-Driven Metabolic Rewiring Reveals Novel Actionable Targets in Cancer
Emanuela Pupo et al.
FRONTIERS IN ONCOLOGY (2019)
Part I of GANNET53: A European Multicenter Phase I/II Trial of the Hsp90 Inhibitor Ganetespib Combined With Weekly Paclitaxel in Women With High-Grade, Platinum-Resistant Epithelial Ovarian Cancer-A Study of the GANNET53 Consortium
Isabelle Ray-Coquard et al.
FRONTIERS IN ONCOLOGY (2019)
A Comparative Analysis of Individual RAS Mutations in Cancer Biology
Carmen Munoz-Maldonado et al.
FRONTIERS IN ONCOLOGY (2019)
Priming anti-tumor immunity by radiotherapy: Dying tumor cell-derived DAMPs trigger endothelial cell activation and recruitment of myeloid cells
Julia Krombach et al.
ONCOIMMUNOLOGY (2019)
BJ-B11, an Hsp90 Inhibitor, Constrains the Proliferation and Invasion of Breast Cancer Cells
Kaisheng Liu et al.
FRONTIERS IN ONCOLOGY (2019)
Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
Lorenzo Galluzzi et al.
CELL DEATH AND DIFFERENTIATION (2018)
Cooperation between Hsp90 and mortalin/GRP75 in resistance to cell death induced by complement C5b-9
Perri Rozenberg et al.
CELL DEATH & DISEASE (2018)
Systemic inflammatory status predict the outcome of k-RAS WT metastatic colorectal cancer patients receiving the thymidylate synthase poly-epitope-peptide anticancer vaccine
Pierpaolo Correale et al.
Oncotarget (2018)
A Phase Ib/II Study of Ganetespib With Doxorubicin in Advanced Solid Tumors Including Relapsed-Refractory Small Cell Lung Cancer
Deepa S. Subramaniam et al.
FRONTIERS IN ONCOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Colorectal Cancer Consensus Molecular Subtypes Translated to Preclinical Models Uncover Potentially Targetable Cancer Cell Dependencies
Anita Sveen et al.
CLINICAL CANCER RESEARCH (2018)
Abscopal, immunological effects of radiotherapy: Narrowing the gap between clinical and preclinical experiences
Nikko Brix et al.
IMMUNOLOGICAL REVIEWS (2017)
Recent Developments in Radiotherapy
Kelvin Yan
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Ganetespib synergizes with cyclophosphamide to improve survival of mice with autochthonous tumors in a mutant p53-dependent manner
Evguenia M. Alexandrova et al.
CELL DEATH & DISEASE (2017)
HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes
Rina M. Mbofung et al.
NATURE COMMUNICATIONS (2017)
DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
Claire Vanpouille-Box et al.
NATURE COMMUNICATIONS (2017)
The immune response to secondary necrotic cells
Monika Sachet et al.
APOPTOSIS (2017)
Monocyte differentiation and antigen-presenting functions
Claudia V. Jakubzick et al.
NATURE REVIEWS IMMUNOLOGY (2017)
Ly6C+ monocyte efferocytosis and cross-presentation of cell-associated antigens
S. R. Larson et al.
CELL DEATH AND DIFFERENTIATION (2016)
A novel HSP90 inhibitor with reduced hepatotoxicity synergizes with radiotherapy to induce apoptosis, abrogate clonogenic survival, and improve tumor control in models of colorectal cancer
Linda Kinzel et al.
ONCOTARGET (2016)
Modern Radiotherapy Concepts and the impact of Radiation on immune Activation
Lisa Deloch et al.
FRONTIERS IN ONCOLOGY (2016)
Spatiotemporal Expression Dynamics of Selectins Govern the Sequential Extravasation of Neutrophils and Monocytes in the Acute Inflammatory Response
Gabriele Zuchtriegel et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Targeting the heat shock response in combination with radiotherapy: Sensitizing cancer cells to irradiation-induced cell death and heating up their immunogenicity
Kirsten Lauber et al.
CANCER LETTERS (2015)
HSP90 inhibition as a means of radiosensitizing resistant, aggressive soft tissue sarcomas
Anne Ernst et al.
CANCER LETTERS (2015)
Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions
Alexander Filatenkov et al.
CLINICAL CANCER RESEARCH (2015)
The novel HSP90 inhibitor AT13387 potentiates radiation effects in squamous cell carcinoma and adenocarcinoma cells
Diana Spiegelberg et al.
ONCOTARGET (2015)
Comparative analysis of KRAS codon 12, 13, 18, 61, and 117 mutations using human MCF10A isogenic cell lines
Britta Stolze et al.
SCIENTIFIC REPORTS (2015)
Tissue Plasminogen Activator Promotes Postischemic Neutrophil Recruitment via Its Proteolytic and Nonproteolytic Properties
Bernd Uhl et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2014)
CCL2/CCR2-Dependent Recruitment of Functional AntigenPresenting Cells into Tumors upon Chemotherapy
Yuting Ma et al.
CANCER RESEARCH (2014)
Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling
A. Ko et al.
CELL DEATH AND DIFFERENTIATION (2014)
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum
Cornelis J. H. van de Velde et al.
EUROPEAN JOURNAL OF CANCER (2014)
STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors
Liufu Deng et al.
IMMUNITY (2014)
The HSP90 inhibitor ganetespib has chemosensitizer and radiosensitizer activity in colorectal cancer
Suqin He et al.
INVESTIGATIONAL NEW DRUGS (2014)
Norm-and hypo-fractionated radiotherapy is capable of activating human dendritic cells
Lorenz Kulzer et al.
JOURNAL OF IMMUNOTOXICOLOGY (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Heat Shock Protein-90 Inhibitors Enhance Antigen Expression on Melanomas and Increase T Cell Recognition of Tumor Cells
Timothy J. Haggerty et al.
PLOS ONE (2014)
Current concepts in clinical radiation oncology
Michael Orth et al.
RADIATION AND ENVIRONMENTAL BIOPHYSICS (2014)
Release of monocyte migration signals by breast cancer cell lines after ablative and fractionated γ-irradiation
Roman Hennel et al.
RADIATION ONCOLOGY (2014)
Colorectal cancer: From prevention to personalized medicine
Gemma Binefa et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
The role of nucleotides and purinergic signaling in apoptotic cell clearance - implications for chronic inflammatory diseases
Jin Chen et al.
FRONTIERS IN IMMUNOLOGY (2014)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Matrix metalloproteinases modulate ameboid-like migration of neutrophils through inflamed interstitial tissue
Max Lerchenberger et al.
BLOOD (2013)
Anticancer Chemotherapy-Induced Intratumoral Recruitment and Differentiation of Antigen-Presenting Cells
Yuting Ma et al.
IMMUNITY (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Combination Therapy with HSP90 Inhibitor 17-DMAG Reconditions the Tumor Microenvironment to Improve Recruitment of Therapeutic T cells
Aparna Rao et al.
CANCER RESEARCH (2012)
Asymmetric Synthesis of Pochonin E and F, Revision of Their Proposed Structure, and Their Conversion to Potent Hsp90 Inhibitors
Ganesan Karthikeyan et al.
CHEMISTRY-A EUROPEAN JOURNAL (2012)
Inhibiting HSP90 to Treat Cancer: A Strategy in Evolution
L. Whitesell et al.
CURRENT MOLECULAR MEDICINE (2012)
Radiation Therapy to Convert the Tumor Into an In Situ Vaccine
Silvia C. Formenti et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2012)
Heat Shock Protein 90-Mediated Peptide-Selective Presentation of Cytosolic Tumor Antigen for Direct Recognition of Tumors by CD4+ T Cells
Takemasa Tsuji et al.
JOURNAL OF IMMUNOLOGY (2012)
Quantitative Proteomics Reveals That Hsp90 Inhibition Preferentially Targets Kinases and the DNA Damage Response
Kirti Sharma et al.
MOLECULAR & CELLULAR PROTEOMICS (2012)
Dying cell clearance and its impact on the outcome of tumor radiotherapy
Kirsten Lauber et al.
FRONTIERS IN ONCOLOGY (2012)
The Efficacy of Radiotherapy Relies upon Induction of Type I Interferon-Dependent Innate and Adaptive Immunity
Byron C. Burnette et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Urokinase-Type Plasminogen Activator Promotes Paracellular Transmigration of Neutrophils Via Mac-1, But Independently of Urokinase-Type Plasminogen Activator Receptor
Christoph A. Reichel et al.
CIRCULATION (2011)
Pancreatic cancers require autophagy for tumor growth
Shenghong Yang et al.
GENES & DEVELOPMENT (2011)
Real-time Imaging Reveals That P2Y2 and P2Y12 Receptor Agonists Are Not Chemoattractants and Macrophage Chemotaxis to Complement C5a Is Phosphatidylinositol 3-Kinase (PI3K)- and p38 Mitogen-activated Protein Kinase (MAPK)-independent
Katrin Isfort et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Drug Combination Studies and Their Synergy Quantification Using the Chou-Talalay Method
Ting-Chao Chou
CANCER RESEARCH (2010)
Secondary necrosis: The natural outcome of the complete apoptotic program
Manuel T. Silva
FEBS LETTERS (2010)
Autocrine Purinergic Receptor Signaling Is Essential for Macrophage Chemotaxis
Moritz Kronlage et al.
SCIENCE SIGNALING (2010)
Targeting the dynamic HSP90 complex in cancer
Jane Trepel et al.
NATURE REVIEWS CANCER (2010)
Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment
Youjin Lee et al.
BLOOD (2009)
Heat Shock Protein 90 Inhibitor 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin Enhances EphA2+ Tumor Cell Recognition by Specific CD8+ T Cells
Mayumi Kawabe et al.
CANCER RESEARCH (2009)
Inhibition of HSP90 with Pochoximes: SAR and Structure-Based Insights
Sofia Barluenga et al.
CHEMBIOCHEM (2009)
Heat Shock Protein-90 Inhibitors Increase MHC Class I-Related Chain A and B Ligand Expression on Multiple Myeloma Cells and Their Ability to Trigger NK Cell Degranulation
Cinzia Fionda et al.
JOURNAL OF IMMUNOLOGY (2009)
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
Michael R. Elliott et al.
NATURE (2009)
Divergent synthesis of a pochonin library targeting HSP90 and in vivo efficacy of an identified inhibitor
Sofia Barluenga et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2008)
Radiation-induced IFN-γ production within the tumor microenvironment influences antitumor immunity
Amit A. Lugade et al.
JOURNAL OF IMMUNOLOGY (2008)
Heat-shock protein 90 associates with N-terminal extended peptides and is required for direct and indirect antigen presentation
Margaret K. Callahan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Local radiation therapy of B16 melanoma tumors increases the generation of tumor antigen-specific effector cells that traffic to the tumor
AA Lugade et al.
JOURNAL OF IMMUNOLOGY (2005)
A high-affinity conformation of Hsp90 confers tumour selectivity on Hsp90 inhibitors
A Kamal et al.
NATURE (2003)
Visualization of leukocyte transendothelial and interstitial migration using reflected light oblique transillumination in intravital video microscopy
TR Mempel et al.
JOURNAL OF VASCULAR RESEARCH (2003)
Accelerated HER-2 degradation enhanced ovarian tumor recognition by CTL. Implications for tumor immunogenicity
A Castilleja et al.
MOLECULAR AND CELLULAR BIOCHEMISTRY (2001)
Role of BAX in the apoptotic response to anticancer agents
L Zhang et al.
SCIENCE (2000)
Analysis of fractalkine receptor CX3CR1 function by targeted deletion and green fluorescent protein reporter gene insertion
S Jung et al.
MOLECULAR AND CELLULAR BIOLOGY (2000)
分享论文
